for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Urogen Announces Positive Data From Pivotal Olympus Trial Evaluating Jelmyto In Patients With Low-Grade Upper Tract Urothelial Cancer

May 15 (Reuters) - Urogen Pharma Ltd:

* UROGEN ANNOUNCES POSITIVE DATA FROM PIVOTAL OLYMPUS TRIAL EVALUATING JELMYTO™ IN PATIENTS WITH LOW-GRADE UPPER TRACT UROTHELIAL CANCER Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up